PATENT CLAIM ANALYSIS

Application Number: 15908723
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
Disclosed herein are recombinantly engineered  influenza viruses  and compositions thereof.

Claim (Index 10):
The recombinantly engineered  influenza virus  of  claim 1 , wherein the insertional mutation is located at or within about 1-5 amino acid residues, of the C-terminal end of the ectodomain of the M2 protein.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14128415', '15125763', '12214414', '11043768', '14219000']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7647390811972468
- 35 USC 102 Novelty (BERT): 0.5351004966971664
- Combined Prediction Score: 0.7417752227472387
- Mean Citation Score: 359.66776
- Max Citation Score: 373.00714
- Similarity Product: 260.4623499001528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test